Extracellular vesicles in cardiac regeneration and aging: mechanisms and translation
Authors:
- Michał PoradaMPMichał Porada
- Adam JanasAJAdam Janas
- Karolina Bajdak-RusinekKBKarolina Bajdak-Rusinek
- 10 November 2025
- journal article
- Published by OAE Publishing Inc. in The Journal of Cardiovascular Aging
- Vol. 5 (4)
Abstract
Myocardial infarction (MI) and age-related cardiac remodeling remain major causes of morbidity and mortality worldwide. Because the adult heart has only limited regenerative capacity, extracellular vesicles (EVs) have emerged as promising acellular mediators of tissue repair, with the potential to mitigate both ischemic injury and age-associated decline. Preclinical studies demonstrate that EVs derived from stem and progenitor cells exert anti-apoptotic, anti-fibrotic, anti-inflammatory, and pro-angiogenic effects. In aged hearts, EVs can help restore metabolic homeostasis, attenuate pro-senescent signaling, and improve functional resilience. Early-phase clinical trials suggest that EV-based or EV-enriched products are feasible and safe, although evidence of efficacy remains limited. This review synthesizes current mechanistic insights into EV-mediated regulation of inflammation, fibrosis, angiogenesis, oxidative and ferroptotic stress, and cellular senescence, underscoring the therapeutic potential of EVs in cardiac regeneration - particularly in older patients with impaired endogenous repair. Importantly, it uniquely integrates the dual roles of EVs in both myocardial infarction repair and cardiac aging, thereby addressing a critical gap in the literature. By linking mechanisms of post-infarction regeneration with age-related cardiac decline, we outline the translational challenges and opportunities of EV-based therapies. Further advances in EV engineering, targeting, dosing, potency assays, and standardization will be essential for successful clinical translation.Keywords
This publication has 88 references indexed in Scilit:
- Towards artificial intelligence-enabled extracellular vesicle precision drug deliveryAdvanced Drug Delivery Reviews, 2023
- Engineering Extracellular Vesicles as Delivery Systems in Therapeutic ApplicationsAdvanced Science, 2023
- Versatility of mesenchymal stem cell-derived extracellular vesicles in tissue repair and regenerative applicationsBiochimie, 2022
- Fibroblast‐mediated intercellular crosstalk in the healthy and diseased heartFEBS Letters, 2021
- Adipose-Derived Mesenchymal Stem Cells-Derived Exosomes Carry MicroRNA-671 to Alleviate Myocardial Infarction Through Inactivating the TGFBR2/Smad2 AxisInflammation, 2021
- Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126Acta Biomaterialia, 2020
- Serum extracellular vesicles promote proliferation of H9C2 cardiomyocytes by increasing miR-17-3pBiochemical and Biophysical Research Communications, 2018
- Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases2017
- Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against SepsisStem Cells, 2017
- Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction modelJournal of Molecular Medicine, 2013